Perspective Therapeutics (CATX) Gains from Investment Securities (2011 - 2026)

Perspective Therapeutics recorded quarterly Gains from Investment Securities of -$78000.0 in Q1 2026, down 133.05% quarter-over-quarter from $236000.0 in Q4 2025, and up 43.48% year-over-year from -$54363.6 in Q1 2025.

Perspective Therapeutics' Gains from Investment Securities history runs 15 years deep, the most recent figure standing at -$78000.0 for Q1 2026.

  • In Q1 2026, Gains from Investment Securities rose 43.48% year-over-year to -$78000.0; the TTM figure through Mar 2026 stood at $60000.0 (down 100.0% YoY), while the FY2025 annual figure was $10.5 million, up 43.12% from the prior year.
  • Gains from Investment Securities came in at -$78000.0 for Q1 2026 at Perspective Therapeutics, down from $236000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $2.0 billion in Q4 2024 to a low of -$645000.0 in Q2 2022.
  • A 5-year average of $220.8 million and a median of $68000.0 in 2022 frame the typical range for Gains from Investment Securities.
  • Across the five-year window, Gains from Investment Securities jumped 406314.67% in 2023 and sank 360.0% in 2025, its largest moves.
  • Perspective Therapeutics' Gains from Investment Securities stood at $150000.0 in 2022, then surged by 406314.67% to $609.6 million in 2023, then jumped by 227.24% to $2.0 billion in 2024, then tumbled by 99.99% to $236000.0 in 2025, then sank by 133.05% to -$78000.0 in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods registered -$78000.0, $236000.0, and -$14000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Perspective Therapeutics 380.23 Mn 380.23 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -78,000.00
Mar 31, 2026 -78,000.00
Dec 31, 2025 236,000.00
Dec 31, 2025 236,000.00
Sep 30, 2025 -14,000.00
Sep 30, 2025 -14,000.00
Jun 30, 2025 -84,000.00
Jun 30, 2025 -84,000.00
Mar 31, 2025 -138,000.00
Mar 31, 2025 -138,000.00
Dec 31, 2024 1.99 Bn
Dec 31, 2024 1.99 Bn
Mar 31, 2024 -30,000.00
Mar 31, 2024 -30,000.00
Dec 31, 2023 609.62 Mn
Dec 31, 2023 609.62 Mn
Jun 30, 2023 44.87 Mn
Jun 30, 2023 44.87 Mn
Dec 31, 2022 150,000.00
Dec 31, 2022 150,000.00
Sep 30, 2022 432,450.00
Sep 30, 2022 432,450.00
Jun 30, 2022 -645,000.00
Jun 30, 2022 -645,000.00
Dec 31, 2021 3,000.00
Dec 31, 2021 3,000.00
Jun 30, 2021 4.51 Mn
Jun 30, 2021 4.51 Mn
Mar 31, 2021 652,000.00
Mar 31, 2021 652,000.00
Dec 31, 2020 625.00
Dec 31, 2020 625.00
Sep 30, 2020 2,500.00
Sep 30, 2020 2,500.00
Jun 30, 2020 -83,000.00
Jun 30, 2020 -83,000.00
Mar 31, 2020 40,000.00
Mar 31, 2020 40,000.00
Dec 31, 2019 30,000.00
Dec 31, 2019 30,000.00
Sep 30, 2019 1.23 Mn
Sep 30, 2019 1.23 Mn
Mar 31, 2019 262,500.00
Mar 31, 2019 262,500.00
Sep 30, 2018 82,500.00
Sep 30, 2018 82,500.00
Jun 30, 2018 3.76 Mn
Jun 30, 2018 3.76 Mn
Mar 31, 2018 15,000.00
Mar 31, 2018 15,000.00
Sep 30, 2017 59,666.00
Sep 30, 2017 59,666.00
Jun 30, 2017 -1,000.00
Jun 30, 2017 -1,000.00
Dec 31, 2016 10,000.00
Dec 31, 2016 10,000.00
Sep 30, 2016 -5,000.00
Sep 30, 2016 -5,000.00
Jun 30, 2016 -7,000.00
Jun 30, 2016 -7,000.00
Jun 30, 2014 430,000.00
Jun 30, 2014 430,000.00
Jun 30, 2013 37,534.00
Jun 30, 2013 37,534.00
Sep 30, 2012 37,534.00
Sep 30, 2012 37,534.00
Jun 30, 2012 2.38 Mn
Jun 30, 2012 2.38 Mn
Jun 30, 2011 2.42 Mn
Jun 30, 2011 2.42 Mn